Saturn V Capital Management »

Rapport Therapeutics shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Rapport Therapeutics shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.6M 70k 23.26